GLP-1 peptides (semaglutide, tirzepatide): Nausea is the most common one, especially in the early weeks when dose is being titrated up
The benefits of Ipamorelin include the following: Increased libido Accelerated weight loss Increased energy and vitality Healthier joints and ligaments Better skin tone and texture Fat reduction Anti-aging Anti-inflammatory Muscle building Strengthens bones Higher quality of sleep Long-term growth hormone production Since Ipamorelin works with the body to produce more growth hormones, there is no shutdown of the natural HGH production
Healthy volunteers are not the population using it Teichman studied healthy adults aged 2161
Treatment Protocols DSIP therapy at Strong Health follows a structured clinical approach: Sleep assessment: Thorough evaluation of sleep patterns, sleep hygiene practices, medical history, and current medications Baseline metrics: Sleep questionnaires, and when indicated, referral for sleep studies to rule out sleep apnea or other primary sleep disorders Protocol design: Physician determines DSIP dosing, timing, and whether combination with other peptides is appropriate Administration: DSIP is typically administered via subcutaneous injection in the evening, 12 hours before desired sleep onset Monitoring: Regular follow-ups to assess sleep quality improvements, adjust dosing, and track any side effects Sleep hygiene integration: Peptide therapy is combined with evidence-based sleep hygiene recommendations for optimal results Safety and Side Effects DSIP has a generally favorable safety profile based on available clinical data
Ipamorelin is a pentapeptide five amino acids with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH and a molecular weight of 711.86 g/mol, first described in 1998
- Si bien Ipamorelin se considera seguro para muchos, debe usarse bajo supervisin profesional
